Scope of the Study
Growth in the use of flow cytometry in stem cell research will help to boost the global flow cytometry market. Flow cytometry is a method used to identify and measure the physical and chemical features of a population of cells or particles. Additionally, it is used in cell counting, cell sorting, detecting biomarker, and protein engineering. There is a large void in diagnostics accessibility, particularly in the developing regions. So, the growing incidences of HIV AIDS and cancer can be measured a substantial growth opportunity for the global flow cytometry market.
The market study is being classified by Type (Cytometry Platforms [Sorters, Analyzers], Replaceable Components [Filter, Laser, Detectors, Others], Accessories, Reagents and Consumables [Antibodies, Dyes, Beads, Solutions, Buffers, Others], Software and Services), by Application (Academic and Clinical Research [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others] and Diagnosis [Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others]) and major geographies with country level break-up. According to AMA, the Global Flow Cytometry market is expected to see growth rate of 9.3%
Becton, Dickinson and Company (United States), Thermo Fisher Scientific, Inc. (United States), Beckman Coulter, Inc. (United States), Merck KGaA (Germany), Luminex Corporation (United States), Sysmex Partec GmbH (Germany), Miltenyi Biotec GmbH (Germany), Agilent Technologies, Inc. (United States), bioMérieux S.A. (France) and Bio-Rad Laboratories, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Sony Biotechnology, Inc. (United States), Enzo Life Sciences, Inc. (United States), Stratedigm, Inc. (United States), Cytonome/ST LLC (United States) and Apogee Flow Systems Ltd. (United Kingdom).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Flow Cytometry market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Flow Cytometry market by Type, Application and Region.
On the basis of geography, the market of Flow Cytometry has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Technology, the sub-segment i.e. Cell-Based will boost the Flow Cytometry market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Commercial Organizations will boost the Flow Cytometry market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growing Prevalence of Cancer and HIV/AIDS
- Upsurge in the Applications of Flow Cytometry in Clinical Research
- Increasing Adoption of Flow Cytometry Techniques in Research and Academia
- The Emergence and Commercial Application of New Technologies in the Field Of Flow Cytometry
- Intensifying Stem Cell Research
- Developing Public-Private Initiatives in the Field Of Immunology and Immuno-Oncology Researches
- Lack of Skilled Professionals
- The Lack of Proper Knowledge
- Growing Availability of Novel Application-Specific Flow Cytometry Products
- Increasing Market Presence in Emerging Countries
- Adoption of Recombinant DNA Technology for Antibody Production
- Inadequate Research Infrastructure across Emerging Countries
- Complexities Related To Reagent Development
Market Leaders and their expansionary development strategies
On 26th March 2019, BD (Becton, Dickinson and Company), a leading global medical technology company has announced the CE-IVD certification for the BD FACSDuet™ automated flow cytometry system. It allows clinical laboratories to expand their efficiency by dropping errors and restraining the manual user interactions required to run assays on the BD FACSLyric™ clinical flow cytometer.
On 18th October 2018, Luminex has acquired MilliporeSigma's flow cytometry portfolio. The deal is established for 75 million dollars, consisting of about 69.9 million dollars to be paid under a stock and asset purchase agreement and about 5.1 million dollars in committed inventory purchases.
Key Target AudienceGovernment Regulatory Bodies, Government and Private Research Organizations and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase